# Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)

Study · id `cardio:ct-nct06535568` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06535568](<https://clinicaltrials.gov/study/NCT06535568>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06535568

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 576 participants.

## Technical summary

Registry record NCT06535568. Randomized; single masking; primary purpose treatment. Start 2026-01-10 (actual); primary completion 2028-01-20 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 576 participants (planned count; ClinicalTrials.gov record NCT06535568, source copy `cardio:ctgov-nct06535568-2026-01-22`, retrieved 2026-11-18)
- Started: 2026-01-10 (actual) (ClinicalTrials.gov record NCT06535568, source copy `cardio:ctgov-nct06535568-2026-01-22`, retrieved 2026-11-18)
- Primary completion: 2028-01-20 (anticipated) (ClinicalTrials.gov record NCT06535568, source copy `cardio:ctgov-nct06535568-2026-01-22`, retrieved 2026-11-18)
- Completion: 2028-02-20 (anticipated) (ClinicalTrials.gov record NCT06535568, source copy `cardio:ctgov-nct06535568-2026-01-22`, retrieved 2026-11-18)
- Countries: Italy (ClinicalTrials.gov record NCT06535568, source copy `cardio:ctgov-nct06535568-2026-01-22`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06535568-2026-01-22`, retrieved 2026-11-18)

## The registry's words

- Brief title: Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)
- Acronym: PIV-EPIC
- Condition: Coronary Disease
- Condition: Heart Diseases
- Condition: Cardiovascular Diseases
- Condition: Myocardial Ischemia
- Condition: Atherosclerosis
- Condition: Arterial Occlusive Diseases
- Condition: Vascular Diseases
- Condition: Coronary Artery Disease
- Condition: Acute Coronary Syndrome
- Condition: Coronary Stenosis
- Condition: Molecular Mechanisms of Pharmacological Action
- Condition: Enzyme Inhibitors
- Condition: MTOR Inhibitors
- Condition: Protein Kinase Inhibitors
- Condition: Physiological Effects of Drugs
- Condition: Immunosuppressive Agents
- Condition: Antineoplastic Agents
- Condition: High Bleeding Risk
- Condition: Single Antiplatelet Therapy
- Condition: Dual Antiplatelet Therapy
- Condition: Cyclooxygenase Inhibitors
- Condition: P2Y12 Inhibitor
- Condition: Platelet Aggregation Inhibitors
- Condition: Aspirin
- Condition: Clopidogrel
- Intervention (Device): Drug-coated balloon
- Intervention (Drug): Single antiplatelet therapy (SAPT)
- Intervention (Drug): Dual antiplatelet therapy (DAPT)
- Lead sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS
- Lead sponsor class: OTHER
- Collaborator: Fundación EPIC
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS (`cardio:org-fondazione-ricerca-e-innovazione-cardiovascolare-ets`)
- Registry lists this organization as a collaborator: Fundación EPIC (`cardio:org-fundacion-epic`)

## Provenance

Content hash: 9a9e08f8e96f90ac0c790011d74bab04f8ac874c333dab29d9a83e33a4a8b27f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
